Table 4.
Univariable logistic regression for 1-year mortality
| Variable | OR (95% CI) | P value |
|---|---|---|
| Age | 1.02 (1.02-1.07) | .0005 |
| Male sex | 0.55 (0.29-1.1) | .076 |
| BMI (kg/m2) | 1.00 (0.98-1.1) | .260 |
| BMI >30 kg/m2 | 1.80 (1.0-3.4) | .046 |
| BSA (m2) | 0.64 (0.21-2.0) | .444 |
| History of cardiac surgery | 1.80 (0.96-3.4) | .069 |
| Atrial fibrillation | 1.70 (1.2-8.0) | .041 |
| Diabetes mellitus | 1.40 (0.83-2.40) | .198 |
| Cardiopulmonary resuscitation | 1.20 (0.68-2.0) | .581 |
| Platelet count per 10/L | 0.95 (0.91-0.98) | .001 |
| Lactate (mmol/L) | 0.99 (0.80-1.20) | .905 |
| Total bilirubin per 10 mg/dL | 3.1 (1.6-6.2) | .001 |
| International normalized ratio | 1.9 (0.92-4.1) | .082 |
| Urea per 10 U/L | 1.1 (1-1.1) | .039 |
| Creatinine (mg/dL) | 1.1 (0.81-1.4) | .709 |
| Lactate dehydrogenase per 1000 mg/dL | 1.40 (0.97-1.90) | .071 |
| MELD per 10 | 1.8 (1.3-2.4) | <.001 |
| MELD-XI per 10 | 1.8 (1.2-2.6) | .003 |
| Blood units during mAFP support therapy per 10 units | 6.4 (1.0-40) | .047 |
| Renal replacement therapy | 1.7 (0.98-2.9) | .057 |
| Invasive ventilation | 1.0 (0.62-1.7) | .897 |
| VA-ECLS before/during mAFP support (%) | 1.3 (0.79-2.2) | .284 |
OR, Odds ratio; CI, confidence interval; BMI, body mass index; BSA, body surface area; MELD, Model of End-Stage Liver Disease; MELD-XI, Model of End-Stage Liver Disease excluding international normalized ratio; VA-ECLS, venoarterial extracorporeal life support; mAFP, microaxial flow pump.